Palvella (PVLA) director adds 445 shares in open-market stock purchase

Rhea-AI Filing Summary

PALVELLA THERAPEUTICS, INC. director George M. Jenkins made an open-market purchase of common stock. On March 30, 2026, he bought 445 shares of Palvella Therapeutics common stock at $112.30 per share. Following this trade, he directly holds 187,616 shares and has an additional 13,516 shares reported as indirectly held through the Eagles Mere Air Museum Foundation.

Insider Trade Summary

Net Buyer: 445 shares ($49,974)

Net Buy 2 txns

Insider JENKINS GEORGE M

Role Director

Bought 445 shs ($50K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	445	$112.30	$50K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 187,616 shares (Direct); Common Stock — 13,516 shares (Indirect, By foundation)

Footnotes (1)

1. [object Object]

Key Figures

Shares purchased: 445 shares Purchase price: $112.30 per share Direct holdings after transaction: 187,616 shares +1 more

4 metrics

Shares purchased 445 shares Open-market purchase on March 30, 2026

Purchase price $112.30 per share Price for common stock on March 30, 2026

Direct holdings after transaction 187,616 shares Common stock directly owned after the purchase

Indirect holdings 13,516 shares Common stock held indirectly by foundation

Key Terms

open-market purchase, indirect ownership, Common Stock, Eagles Mere Air Museum Foundation

4 terms

open-market purchase financial

"transaction_action": "open-market purchase""

An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.

indirect ownership financial

""direct_or_indirect": "I", "nature_of_ownership": "By foundation""

Common Stock financial

""security_title": "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Eagles Mere Air Museum Foundation financial

"footnote states: "Eagles Mere Air Museum Foundation.""

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

JENKINS GEORGE M

(Last) (First) (Middle)

C/O PALVELLA THERAPEUTICS, INC.

353 W. LANCASTER AVENUE, SUITE 200

(Street)

WAYNE PENNSYLVANIA 19087

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PALVELLA THERAPEUTICS, INC. [ PVLA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/30/2026		P		445	A	$112.3	187,616	D
Common Stock								13,516	I	By foundation(1)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Eagles Mere Air Museum Foundation.

	/s/ Kathleen A. McGowan, Attorney-in-Fact	04/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Palvella Therapeutics (PVLA) director George M. Jenkins do in this Form 4?

George M. Jenkins reported an open-market purchase of Palvella Therapeutics common stock. He bought 445 shares at $112.30 per share, increasing his direct holdings and signaling additional personal exposure to the company’s equity through this relatively small transaction.

How many Palvella Therapeutics (PVLA) shares did George M. Jenkins buy and at what price?

Jenkins bought 445 shares of Palvella Therapeutics common stock in an open-market transaction. The reported purchase price was $112.30 per share, documenting the exact size and pricing of this insider buy in the Form 4 filing with the SEC.

What are George M. Jenkins’ total direct Palvella Therapeutics (PVLA) holdings after this trade?

After the reported purchase, Jenkins directly holds 187,616 shares of Palvella Therapeutics common stock. This figure reflects his direct ownership position as disclosed in the Form 4 and provides context for the scale of the 445-share open-market transaction.

Does George M. Jenkins have any indirect ownership in Palvella Therapeutics (PVLA)?

Yes. The Form 4 shows 13,516 Palvella Therapeutics shares as indirectly owned. These shares are held "By foundation," identified in a footnote as the Eagles Mere Air Museum Foundation, indicating an additional, indirect equity interest associated with the reporting person.

What does the Eagles Mere Air Museum Foundation reference mean in the PVLA Form 4?

A footnote in the filing identifies the indirect holdings as "Eagles Mere Air Museum Foundation." This indicates that 13,516 shares of Palvella Therapeutics common stock are reported as held by that foundation, separate from Jenkins’ 187,616 directly owned shares.